Home/Filings/4/0001437749-23-021073
4//SEC Filing

Cohen Fred E 4

Accession 0001437749-23-021073

CIK 0001668243other

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 6:06 PM ET

Size

4.5 KB

Accession

0001437749-23-021073

Insider Transaction Report

Form 4
Period: 2023-07-26
Cohen Fred E
Director
Transactions
  • Award

    Ordinary Shares

    2023-07-26$9.54/sh+69,339$661,49469,339 total(indirect: by Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer)
Footnotes (1)
  • [F1]Represents the reporting person's proportionate interest in shares acquired by entities affiliated with Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer

Issuer

UroGen Pharma Ltd.

CIK 0001668243

Entity typeother

Related Parties

1
  • filerCIK 0001339358

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 6:06 PM ET
Size
4.5 KB